NVST
Price
$23.73
Change
-$0.22 (-0.92%)
Updated
Sep 28, 04:59 PM (EDT)
Capitalization
3.85B
37 days until earnings call
Intraday BUY SELL Signals
WST
Price
$375.66
Change
+$5.22 (+1.41%)
Updated
Sep 28, 04:59 PM (EDT)
Capitalization
26.07B
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVST vs WST

NVST vs WST Comparison Chart in %
View a ticker or compare two or three
VS
NVST vs. WST commentary
Sep 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Buy and WST is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
NVST vs WST: Fundamental Ratings
NVST
WST
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8748
PRICE GROWTH RATING
1..100
6031
P/E GROWTH RATING
1..100
8221
SEASONALITY SCORE
1..100
9085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (57) in the null industry is in the same range as WST (77) in the Medical Specialties industry. This means that NVST’s stock grew similarly to WST’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as WST (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to WST’s over the last 12 months.

WST's SMR Rating (48) in the Medical Specialties industry is somewhat better than the same rating for NVST (87) in the null industry. This means that WST’s stock grew somewhat faster than NVST’s over the last 12 months.

WST's Price Growth Rating (31) in the Medical Specialties industry is in the same range as NVST (60) in the null industry. This means that WST’s stock grew similarly to NVST’s over the last 12 months.

WST's P/E Growth Rating (21) in the Medical Specialties industry is somewhat better than the same rating for NVST (82) in the null industry. This means that WST’s stock grew somewhat faster than NVST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTWST
RSI
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
58%
Momentum
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
69%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
69%
Advances
ODDS (%)
Bullish Trend 7 days ago
66%
Bullish Trend 6 days ago
68%
Declines
ODDS (%)
Bearish Trend 11 days ago
69%
Bearish Trend 4 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
59%
Bearish Trend 4 days ago
65%
Aroon
ODDS (%)
Bearish Trend 4 days ago
77%
N/A
COMPARISON
Comparison
Sep 28, 2026
Stock price -- (NVST: $23.95 vs. WST: $370.44)
Brand notoriety: NVST and WST are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NVST: 111% vs. WST: 67%
Market capitalization -- NVST: $3.85B vs. WST: $26.07B
NVST [@Pharmaceuticals: Other] is valued at $3.85B. WST’s [@Pharmaceuticals: Other] market capitalization is $26.07B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $143.14B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green while WST’s FA Score has 2 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • WST’s FA Score: 2 green, 3 red.
According to our system of comparison, WST is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 4 TA indicator(s) are bullish while WST’s TA Score has 5 bullish TA indicator(s).

  • NVST’s TA Score: 4 bullish, 5 bearish.
  • WST’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, WST is a better buy in the short-term than NVST.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а +2.57% price change this week, while WST (@Pharmaceuticals: Other) price change was +2.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.40%. For the same industry, the average monthly price growth was -2.48%, and the average quarterly price growth was +16.57%.

Reported Earning Dates

NVST is expected to report earnings on Nov 04, 2026.

WST is expected to report earnings on Oct 22, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
NVST
Daily Signal:
Gain/Loss:
WST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAVA1.810.11
+6.47%
Endava plc
CLMB31.650.49
+1.57%
Climb Global Solutions Inc
SBAC166.150.03
+0.02%
SBA Communications Corp
KC9.66-0.08
-0.82%
Kingsoft Cloud Holdings Limited
HIHO0.91-0.02
-2.16%
Highway Holdings Limited

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been closely correlated with ALGN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVST jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-0.50%
ALGN - NVST
70%
Closely correlated
+0.79%
XRAY - NVST
60%
Loosely correlated
-1.36%
BIO - NVST
57%
Loosely correlated
-1.69%
A - NVST
55%
Loosely correlated
-0.03%
MTD - NVST
52%
Loosely correlated
-0.49%
More

WST and

Correlation & Price change

A.I.dvisor indicates that over the last year, WST has been loosely correlated with STVN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WST jumps, then STVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WST
1D Price
Change %
WST100%
-0.85%
STVN - WST
49%
Loosely correlated
-1.17%
BLFS - WST
36%
Loosely correlated
-0.23%
RGEN - WST
34%
Loosely correlated
-0.51%
QDEL - WST
33%
Loosely correlated
+2.34%
NVST - WST
32%
Poorly correlated
-0.50%
More